These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38961354)

  • 1. An updated meta-analysis of optimal medical therapy with or without invasive therapy in patients with stable coronary artery disease.
    Bi L; Geng Y; Wang Y; Li S; Sun K; Guo Y; Zhang O; Zhang P
    BMC Cardiovasc Disord; 2024 Jul; 24(1):335. PubMed ID: 38961354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta-Analysis of Contemporary Randomized Controlled Trials.
    Soares A; Boden WE; Hueb W; Brooks MM; Vlachos HEA; O'Fee K; Hardi A; Brown DL
    J Am Heart Assoc; 2021 Jan; 10(2):e019114. PubMed ID: 33442990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
    Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention vs coronary artery bypass grafting for left main coronary artery disease? A systematic review and meta-analysis of randomized controlled trials.
    Sharma SP; Dahal K; Khatra J; Rosenfeld A; Lee J
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28371437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Barbarawi M; Zayed Y; Hamid K; Kheiri B; Barbarawi O; Sundus S; Rashdan L; Alabdouh A; Chahine A; Bachuwa G; Alkotob ML
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1184-1189. PubMed ID: 30842042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of optimal medical therapy with or without percutaneous coronary intervention in patients with stable coronary artery disease.
    Shah R; Nayyar M; Le FK; Labroo A; Nasr A; Rashid A; Davis DA; Weintraub WS; Boden WE
    Coron Artery Dis; 2022 Mar; 33(2):91-97. PubMed ID: 33878073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Clinical, Surgical and Percutaneous Treatment to Prevent Cardiovascular Events in Patients Referred for Elective Coronary Angiography: An Observational Study.
    Almeida AS; Fuchs SC; Fuchs FC; Silva AG; Lucca MB; Scopel S; Fuchs FD
    Vasc Health Risk Manag; 2020; 16():285-297. PubMed ID: 32764949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: A meta-analysis of randomized controlled trials and propensity score adjusted studies.
    Iannaccone M; D'ascenzo F; Piazza F; De Benedictis M; Doronzo B; Behnes M; Garbo R; Mashayekhi K
    Catheter Cardiovasc Interv; 2019 May; 93(6):E320-E325. PubMed ID: 30549199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.
    Pursnani S; Korley F; Gopaul R; Kanade P; Chandra N; Shaw RE; Bangalore S
    Circ Cardiovasc Interv; 2012 Aug; 5(4):476-90. PubMed ID: 22872053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
    Farkouh ME; Sidhu MS; Brooks MM; Vlachos H; Boden WE; Frye RL; Hartigan P; Siami FS; Bittner VA; Chaitman BR; Mancini GBJ; Fuster V
    J Am Coll Cardiol; 2019 Feb; 73(4):400-411. PubMed ID: 30704571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
    Mancini GB; Farkouh ME; Brooks MM; Chaitman BR; Boden WE; Vlachos H; Hartigan PM; Siami FS; Sidhu MS; Bittner V; Frye R; Fuster V
    J Am Coll Cardiol; 2016 Sep; 68(10):985-95. PubMed ID: 27585501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta-Analysis of Randomized Trials.
    Ahmad Y; Howard JP; Arnold A; Prasad M; Seligman H; Cook CM; Warisawa T; Shun-Shun M; Ali Z; Parikh MA; Al-Lamee R; Sen S; Francis D; Moses JW; Leon MB; Stone GW; Karmpaliotis D
    J Am Heart Assoc; 2020 Jun; 9(12):e015263. PubMed ID: 32476540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
    Atti V; Gwon Y; Narayanan MA; Garcia S; Sandoval Y; Brilakis ES; Basir MB; Turagam MK; Khandelwal A; Mena-Hurtado C; Mamas MA; Abbott JD; Bhatt DL; Velagapudi P
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1571-1582. PubMed ID: 32646699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up.
    Iqbal J; Zhang YJ; Holmes DR; Morice MC; Mack MJ; Kappetein AP; Feldman T; Stahle E; Escaned J; Banning AP; Gunn JP; Colombo A; Steyerberg EW; Mohr FW; Serruys PW
    Circulation; 2015 Apr; 131(14):1269-77. PubMed ID: 25847979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials.
    Pasceri V; Patti G; Pelliccia F; Gaudio C; Speciale G; Mehran R; Dangas GD
    JACC Cardiovasc Interv; 2018 May; 11(9):833-843. PubMed ID: 29747913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
    Mahmoud AN; Elgendy IY; Mentias A; Saad M; Ibrahim W; Mojadidi MK; Nairooz R; Eshtehardi P; David Anderson R; Samady H
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):541-552. PubMed ID: 28296170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
    Spertus JA; Maron DJ; Cohen DJ; Kolm P; Hartigan P; Weintraub WS; Berman DS; Teo KK; Shaw LJ; Sedlis SP; Knudtson M; Aslan M; Dada M; Boden WE; Mancini GB;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):409-18. PubMed ID: 23838107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Repeat Revascularization in Percutaneous Coronary Intervention Randomized Controlled Trials as a Surrogate for Mortality: A Meta-Regression Analysis.
    Khan SU; Lone AN; Akbar UA; Arshad HB; Arshad A; Arora S; Kaluski E; Aoun J; Goel SS; Shah AR; Kleiman NS
    Curr Probl Cardiol; 2023 Apr; 48(4):101555. PubMed ID: 36529233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials.
    Elgendy IY; Wen X; Mahmoud A; Bavry AA
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):501-505. PubMed ID: 26524970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.